12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

BC Sera Dx: Phase II data

A Russian Phase II trial showed that OTraces' BC Sera Dx blood test was 98% accurate for detecting breast...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >